Research Article
The Success of Treatment Free Remission in Chronic Myeloid Leukaemia in Clinical Practice: A Single-Centre Retrospective Experience from South Africa
Table 5
Factors predicting treatment-free response outcome.
| Number | Successful TFR n = 9 | Failed TFR n = 3 | value |
| Age at diagnosis in years, median [range]† | 50 [29–66] | 53 [45–59] | 0.60 | Total duration on TKI in months†, median [range] | 137 [87–192] | 96 [87–97] | 0.02 | Duration of DMR in months†, median [range] | 99 [83–113] | 70 [43–82] | 0.16 | Sokal score, n (%) | | | 0.50 | Low | 5 (56) | 1 (33) | | Intermediate | 1 (11) | N/A | | High | 1 (11) | 2 (67) | | Indeterminate | 2 (22) | N/A | | Exposure to IFNα, n (%) | | | 0.90 | No | 7 (78) | 3 (100) | | Yes | 2 (22) | 0 (0) | | Withdrawal symptoms, n (%) | | | 0.50 | No | 3 (33) | 2 (67) | | Yes | 6 (67) | 1 (33) | |
|
|
†Two-sample Wilcoxon rank-sum (Mann–Whitney) test; Fisher’s exact; IQR: interquartile range; MR: deep molecular remission; IFN α: interferon alpha; TKI: tyrosine kinase inhibitor. |